A patients’ view of OA: the Global Osteoarthritis Patient Perception Survey (GOAPPS), a pilot study

Abstract

Background Globally, osteoarthritis (OA) is the third condition associated with disability. There is still poor treatment in OA but science holds the key to finding better treatments and a cure. It is essential to learn what’s important to patients from them to implement the most effective OA management. The OA Patients Task Force, conducted the Global OA Patient Perception Survey (GOAPPS)-the first global survey made by patients to analize the quality of life (QoL) & patient perceptions of care. The goal was to collect data on OA patients’ perception of OA to understand patients’ needs and expectations to improve OA management. Methods Observational, cross-sectional study by online survey data collection from six countries, translated into three languages. The questionnaire was comprised of 3 sections: patient demographics and clinical symptomology characteristics; relationship with physicians: perception of attention, treatment, and information provided; and OA impact on daily activity and QoL. The results of the survey were evaluated using the Limited Data Set. The survey results were analyzed using descriptive statistics to characterize the patients’ answers. Additionally, Cronbach’s alpha was calculated to determine internal consistency validity. Results A total of 1512 surveys were completed in 6 countries. 84.2% of respondents reported pain/tenderness and 91.1% experienced limitations to physical activities. 42.3% of patients were not satisfied with their current OA treatment. 86% had comorbidities, especially hypertension, and obesity. 51.3 and 78% would like access to additional drug or additional non-drug/non-surgical treatments respectively. 48.2% of patients perceived their QoL to be affected by OA. The Cronbach’s alpha was 0.61. Conclusions OA has a significant impact on patients’ daily activities and their desire to play an active role in managing this disease. Patients are seeking additional treatments, especially no pharmacological/no surgical treatments stressing the need for investing in clinical research, implementing OA preventive measures, and managing interventions to improve the healthcare value chain in OA.

Giving an account of patients' experience: A qualitative study on the care process of hip and knee osteoarthritis

“… 40 Moreover, evidence showed that individuals with OA are seeking non‐pharmacological and non‐surgical treatments for their conditions, and they want more information about these treatments, which highlights the likelihood that they might be open to undergoing exercise and physiotherapy interventions if educated on their benefits. 41 , 42 This was also retrieved in our interviews in which patients understood the importance of being active and saw exercise as a concrete support to their care, something that one can see while doing it, in contrast to medications and supplements that do not immediately show tangible effects.…”

Experience of the COVID-19 pandemic as lived by patients with hip and knee osteoarthritis: an Italian qualitative study

“…However, a study by Vitaloni et al concluded that patients are seeking non-pharmacological and non-surgical treatments for their conditions which highlights the possibility that patients might be open to undergo exercise and physiotherapy interventions if educated on their benefits and importance. 47 …”

Biomechanics Beyond the Lab: Remote Technology for Osteoarthritis Patient Data - A Scoping Review

“…With no cure, and no proven interventions able to stop its' progression (OARSI 2016), it is a major cause of disability worldwide with increasing prevalence. The consequences of OA impact signi cantly on individuals and wider society (Versus Arthritis 2021), highlighting the urgent need for increased investment into large scale scienti c and clinical research (Vitaloni et al 2020).…”